If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

or COPD, was the sixth leading cause of death in the U.S. in 2020. Every five minutes, an American is diagnosed with the life-changing disease. Until recently, the primary treatment options were ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

a once-daily dry powder inhaler for treatment of COPD in routine clinical practice in a new-user, 1:1 propensity score-matched cohort study. The study included 20,388 propensity score-matched ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations of asthma and COPD in over 50 years. In the time it has taken you to ...